期刊文献+

产前诊断样本中母体细胞污染对染色体微阵列技术检测的影响 被引量:2

Interfering effect of maternal cell contamination on invasive prenatal chromosome microarray analysis
原文传递
导出
摘要 目的评估产前诊断样本中母体细胞污染(MCC)对染色体微阵列技术(CMA)检测拷贝数变异(CNV)的影响。方法前瞻性研究。挑选2016年12月至2018年8月于杭州市妇产科医院产前诊断中心行羊水产前诊断且经CMA检测出拷贝数变异的DNA标本5份,加入正常女性基因组DNA以模拟不同比例母体细胞污染。采用Agilent微阵列染色体芯片180K CGH(Agilent 180K CGH)对模拟标本进行检测,检测结果通过Agilent CytoGenomics软件进行分析。结果当MCC>38.4%(95%可信区间:36.6%~40.2%)时重复CNV无法检出,MCC>41.3%(95%可信区间:39.9%~42.7%)时缺失CNV无法检出,且随MCC比例增高,CNV检出率逐步降低;大片段的CNV较小片段CNV对MCC耐受程度高;相同大小CNV,缺失型CNV的检出能力较重复型略微升高。在男性标本中,当MCC>10%时,可通过微阵列检测到X/Y染色体发生位移。结论MCC高于一定比例时可以对CMA检测CNV产生影响。基于Agilent 180K CGH对MCC模拟物的检测结果及CNV检测特异性原则,鉴于保守原则,本中心Agilent 180K CGH的MCC阈值设定为30%。 Objective To access the effect of maternal cell contamination(MCC)on the detection of copy number variation(CNV)by chromosome microarray analysis(CMA)in prenatal diagnostic samples.Methods Amniotic fluid DNA samples were collected from Department of Prenatal Diagnosis(Screening)Centre of Hangzhou Women′s Hospital from December 2016 to August 2018.Copy number variations(CNVs)were identified in these DNA samples by CMA and normal female genomic DNA was added to simulate different proportions of maternal cells contamination.The simulated samples were tested using an Agilent microarray chromosome chip 180K CGH(Agilent 180K CGH)and the results were analyzed by Agilent CytoGenomics software.Results The results showed that duplications of CNV could not be detected at>38.4%MCC.Deletions of CNV could not be detected at>41.3%of MCC.With the increase of MCC ratio,the detection rate of CNV decreased gradually.The array and software allowed detection of longer copy-number variations at higher levels of maternal cell contamination than shorter copy-number variations.For the same size CNV,the detection ability of the deleted CNV was slightly higher than that of duplication.In the male sample,the observable shift of the X/Y chromosome ratio at>10%MCC can be detected by the microarray.Conclusions When the MCC is higher than a particular ratio,it can affect the CMA detection of CNV.Based on the Agilent 180K CGH detection results for MCC mimics and the CNV detection specificity principle,the MCC threshold of the Agilent 180K CGH is set to 30%in view of conservative principles.
作者 卢莎 王昊 梁丹军 任杰 胡文胜 Lu Sha;Wang Hao;Liang Danjun;Ren Jie;Hu Wensheng;无(Department of Prenatal Diagnosis(Screening)Centre,Hangzhou Women′s Hospital,Hangzhou 310008,China;Department of Pathology and Pathophysiology,Zhejiang University School of Medicine,Hangzhou 310058,China;Hangzhou Joingenome Diagnostics,Hangzhou 311188,China)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2020年第2期153-159,共7页 Chinese Journal of Laboratory Medicine
基金 国家卫生健康委科学研究基金——浙江省医药卫生重大科技计划项目(WKJ-ZJ-1911) 杭州市社会发展科研主动设计项目(20180417A02)。
关键词 羊水 产前诊断 微阵列分析 DNA拷贝数变异 Amniotic fluid Prenatal diagnosis Microarray analysis DNA copy number variations
  • 相关文献

参考文献3

二级参考文献32

  • 1丁华新,杨晓苏,肖波,吴志国,张丽芳.脊髓性肌萎缩症SMN基因拷贝数定量分析[J].中华医学遗传学杂志,2004,21(2):153-155. 被引量:8
  • 2申本昌,张成,孙筱放,张慧敏,李少英.Duchenne肌营养不良症患者及携带者的基因缺失和重复突变检测[J].中华医学遗传学杂志,2007,24(4):460-463. 被引量:2
  • 3Welch RA, Salem-EIgharib S,Wiktor AE, et al. Operatorexperience and sample quality in genetic amniocentesis. Am JObstet Gynecol, 2006, 194: 189-191.
  • 4Stojilkovic-Mikic T,Mann K, Docherty Z, et al. Maternal cellcontamination of prenatal samples assessed by QF-PCRgenotyping. Prenat Diagn, 2005 , 25:79-83.
  • 5Bryndorf T, Christensen B, Xiang Y,et al. Prenatal diagnosis byfluorescence in situ hybridization on chorionic villus cells:nonsignificance of maternal cell contamination. Fetal Diagn Ther,1994, 9:73-76.
  • 6Schrijver I,Cherny SC,Zehnder JL. Testing for maternal cellcontamination in prenatal samples : a comprehensive survey ofcurrent diagnostic practices in 35 molecular diagnosticlaboratories. J Mol Diagn, 2007,9:394400.
  • 7Winsor EJ, Akoury H, Chitayat D, et al. The role of molecularmicrosatellite identity testing to detect sampling errors in prenataldiagnosis. Prenat Diagn, 2010,30:746-752.
  • 8Nagan N, Faulkner NE, Curtis C, et al. MCC GuidelinesWorking Group of the Association for Molecular Pathology ( AMP)Clinical Practice Committee. Laboratory guidelines for detection,interpretation, and reporting of maternal cell contamination inprenatal analyses a report of the association for molecularpathology. J Mol Diagn, 2011,13:7-11.
  • 9Macdonald F. Practice of prenatal diagnosis in the UK. ClinRisk, 2008,14:218-221.
  • 10Brady PD, Vermeesch JR. Genomic microarrays: a technology overview[J]. Prenat Diagn, 2012,32:336-343.

共引文献300

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部